Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinations

Medicine and Dentistry

• Acquired Mutation 20%
• Anticarcinogen 20%
• Cancer Growth 20%
• Carcinogenesis 60%
• Cell Signaling Pathway 20%
• Combination Drug 100%
• Combination Therapy 60%
• Drug Action 20%
• Drug Delivery System 40%
• Drug Resistance 40%
• ErbB 20%
• In Silico 20%
• Malignant Neoplasm 20%
• Pharmacotherapy 20%
• Protein Kinase B 20%
• Receptor 20%
• Sigmoid 20%
• Treatment Response 100%

Biochemistry, Genetics and Molecular Biology

• Acquired Mutation 33%
• Anticancer 33%
• Carcinogenesis 100%
• Cellular Signalling Network 66%
• Drug Mechanism 33%
• Drug Resistance 66%
• Drug Targeting 66%
• Drug Therapy 33%
• ErbB 33%
• Protein Kinase B 33%
• System Analysis 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acquired Mutation 20%
• Anticarcinogen 20%
• Cancer Growth 20%
• Carcinogenesis 60%
• Combination Drug 100%
• Combination Therapy 60%
• Drug Action 20%
• Drug Delivery System 40%
• Drug Resistance 40%
• Malignant Neoplasm 20%
• Pharmacotherapy 20%
• Protein Kinase B 20%
• Receptor 20%